U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
74117411Intestinal Lavage for the Treatment of Severe C. Difficile InfectionsNot yet recruitingNo Results AvailableClostridium DifficileProcedure: London Protocol|Drug: Vancomycin|Drug: PEG|Drug: Metronidazolehttps://ClinicalTrials.gov/show/NCT02466698
74127412Testing the Ability of JNJ-18038683 to Improve Cognition and Reduce Depressive Symptoms in Stable Bipolar PatientsNot yet recruitingNo Results AvailableBipolar DisorderDrug: JNJ-18038683https://ClinicalTrials.gov/show/NCT02466685
74137413The Role and Effect of Anemia in Children With PneumoniaRecruitingNo Results AvailableAnemia|PneumoniaOther: none - observational onlyhttps://ClinicalTrials.gov/show/NCT02466672
74147414[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT02466659
74157415Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis PatientsCompletedNo Results AvailableAggressive PeriodontitisDrug: Klorhex® Gel, rinse and sprey|Procedure: Conventional IPT|Procedure: Full-mouth IPThttps://ClinicalTrials.gov/show/NCT02466646
74167416Effect of Monitoring System Design on Response Time to Cardiac ArrhythmiasNot yet recruitingNo Results AvailableArrhythmias, CardiacOther: In-hospital cardiac monitoring methodhttps://ClinicalTrials.gov/show/NCT02466633
74177417A Comparison of Pediatric Weight Estimation Methods in Thai ChildrenActive, not recruitingNo Results AvailableBody Weighthttps://ClinicalTrials.gov/show/NCT02466620
74187418Study of Stimulus Parameters in Flicker Electroretinogram (ERG)RecruitingNo Results AvailableRetinopathyDevice: RETeval color flicker ERG|Device: RETeval dilated versus un-dilated flicker ERG|Other: pupil dilationhttps://ClinicalTrials.gov/show/NCT02466607
74197419Impact of Active Thermoregulation on the Microcirculation of Free FlapsCompletedNo Results AvailableMicrocirculation|Thermoregulation|Free FlapDevice: Hilotherm Clinic®https://ClinicalTrials.gov/show/NCT02466594
74207420Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease ActivityRecruitingNo Results AvailableRheumatoid ArthritisDrug: Sulphasalazine + Hydroxychloroquine OR Prednisolone|Biological: Cimzia|Biological: Orencia|Biological: RoActemrahttps://ClinicalTrials.gov/show/NCT02466581
74217421Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the LungNot yet recruitingNo Results AvailableLung Cancer|Adenocarcinoma of the LungDrug: Nivolumab|Biological: GM.CD40L Vaccinehttps://ClinicalTrials.gov/show/NCT02466568
74227422Music Therapy in Sickle Cell Transition StudyRecruitingNo Results AvailableSickle Cell DiseaseBehavioral: Music Therapyhttps://ClinicalTrials.gov/show/NCT02466555
74237423Analgesic Effect of Intraoperative Esmolol in MastectomiesRecruitingNo Results AvailablePostoperative PainDrug: Placebo group|Drug: Esmolol grouphttps://ClinicalTrials.gov/show/NCT02466542
74247424Natural History of Spinal Muscular Atrophy Type 1 in TaiwanActive, not recruitingNo Results AvailableSpinal Muscular Atrophy (SMA)https://ClinicalTrials.gov/show/NCT02466529
74257425Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3RecruitingNo Results AvailableNon-Alcoholic Steatohepatitis (NASH)Drug: GS-4997|Biological: SIMhttps://ClinicalTrials.gov/show/NCT02466516
74267426Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal BlockCompletedNo Results AvailableAsthma|Chronic Obstructive Pulmonary Disease (COPD)Drug: Fluticasone propionate|Drug: Salmeterol (as xinafoate)https://ClinicalTrials.gov/show/NCT02466503
74277427Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential HypertensionCompletedNo Results AvailableHypertension, EssentialDrug: Fimasartan|Drug: Fimasartan; Hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT02466490
74287428Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive DisorderRecruitingNo Results AvailableDepressive Disorder, Major|Depression|Depressive DisorderGenetic: GeneSight Psychotropic (GEN)|Genetic: Enhanced-GeneSight Psychotropic (E-GEN)|Other: Treatment as Usual (TAU)https://ClinicalTrials.gov/show/NCT02466477
74297429Microporous Polysaccharide Hemospheres EpistaxisEnrolling by invitationNo Results AvailableEpistaxisDevice: Microporous Polysaccharide Hemospheres|Device: Nasal Tamponhttps://ClinicalTrials.gov/show/NCT02466464
74307430Study in Children With the Diagnosis of CDH and EACompletedNo Results AvailableDiaphragmatic Hernia|Oesophageal AtresiaOther: Questionnaireshttps://ClinicalTrials.gov/show/NCT02466451
74317431Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)Not yet recruitingNo Results AvailableInfectionDrug: Piperacillin-tazobactamhttps://ClinicalTrials.gov/show/NCT02466438
74327432Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)RecruitingNo Results AvailableAttention-Deficit Hyperactivity Disorder (ADHD)Drug: SHP465|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02466425
74337433Nicotine Pharmacokinetic Profile of the CHTP 1.1 MActive, not recruitingNo Results AvailableSmokingOther: CHTP 1.1 M|Other: mCChttps://ClinicalTrials.gov/show/NCT02466412
74347434POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle GlaucomaRecruitingNo Results AvailableGlaucomaDrug: POLAT-001|Drug: Latanoprost ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT02466399
74357435Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity DisorderRecruitingNo Results AvailableAttention-deficit/Hyperactivity DisorderDrug: SPD489https://ClinicalTrials.gov/show/NCT02466386
74367436Pharmacokinetics and Clinical Effects of Escalating Doses of Clonidine in ICU PatientsNot yet recruitingNo Results AvailableDelirium|Critical IllnessDrug: Clonidine (Catapresan®) 0,150 mg/ml, ampoule 1 mlhttps://ClinicalTrials.gov/show/NCT02466373
74377437What Are the Brakes and Levers of Physical Activity Practice for Patients With Chronic Lower Back Pain?CompletedNo Results AvailableNon-specific Chronic Lower Back PainBehavioral: Back Belief questionnaire|Behavioral: QUEBEC scale|Behavioral: Fear Avoidance beliefs questionnaire|Behavioral: Visual analog scale|Behavioral: individual interviews|Behavioral: Focus groupshttps://ClinicalTrials.gov/show/NCT02466360
74387438Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal BlockCompletedNo Results AvailableAsthma|Chronic Obstructive Pulmonary Disease (COPD)Drug: Fluticasone propionate|Drug: Salmeterol (as xinafoate)https://ClinicalTrials.gov/show/NCT02466347
74397439CGRP's Cluster Headache Inducing Abilities in Cluster Headache PatientsNot yet recruitingNo Results AvailableCluster HeadacheDrug: Calcitonin-Gene Related Peptidehttps://ClinicalTrials.gov/show/NCT02466334
74407440Anatomical Shoulderâ„¢ IR StudyActive, not recruitingNo Results AvailableCuff-tear ArthropathyProcedure: Inverse/Reverse Shoulder Arthroplastyhttps://ClinicalTrials.gov/show/NCT02466321

* Görseller ve İçerik tekif hakkına sahip olabilir